Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S11.46
P/E—
Fwd P/E29.25
PEG1.78
52W— – —
RSI—
Target$484.6 (+37.2%)
Beta1.46
Div—
Loading chart…
RSI (14)
Loading patterns…
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 39
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
2Bullish
3Bearish
0Neutral
▲ Double Bottom — Two lows ~$449.53 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$397.10 — bullish reversal confirmed
▼ Bear Flag — Breakdown after -11% pole — bearish continuation
▼ Bear Flag — Breakdown after -8% pole — bearish continuation
▼ Double Top — Two peaks ~$437.35 — bearish reversal confirmed
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$484.6
+37.2% upside
Low $324
—
High $685
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Raymond James | Outperform | — | ↔ Maintain | 2026-07-17 |
| Piper Sandler | Overweight | — | ↔ Reiterate | 2026-07-17 |
| JP Morgan | Overweight | — | ↔ Maintain | 2026-07-17 |
| Mizuho | Neutral | — | ↔ Maintain | 2026-07-17 |
| Wells Fargo | Overweight | — | ↔ Maintain | 2026-07-17 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-07-17 |
| Evercore ISI Group | In-Line | — | ↔ Maintain | 2026-07-17 |
| RBC Capital | Outperform | — | ↔ Maintain | 2026-07-17 |
| Stifel | Buy | — | ↔ Maintain | 2026-07-17 |
| Citigroup | Buy | — | ↔ Maintain | 2026-07-17 |
| Bernstein | Outperform | — | ↔ Maintain | 2026-07-17 |
| Leerink Partners | Outperform | — | ↔ Maintain | 2026-07-17 |
| Baird | Outperform | — | ↔ Maintain | 2026-07-17 |
| BTIG | Buy | — | ↔ Maintain | 2026-07-17 |
| Truist Securities | Buy | — | ↔ Maintain | 2026-07-16 |
| BMO Capital | Outperform | — | ● Initiate | 2026-07-09 |
| B of A Securities | Buy | — | ↔ Maintain | 2026-05-18 |
| Barclays | Overweight | — | ↔ Maintain | 2026-04-23 |
| Goldman Sachs | Buy | — | ↔ Maintain | 2026-04-09 |
| UBS | Neutral | — | ↔ Maintain | 2026-03-17 |
| Freedom Capital Markets | Buy | Hold → Buy | ▲ Upgrade | 2026-01-27 |
| Freedom Broker | Buy | Hold → Buy | ▲ Upgrade | 2026-01-26 |
Raymond James
2026-07-17
Outperform
↔ Maintain
Piper Sandler
2026-07-17
Overweight
↔ Reiterate
JP Morgan
2026-07-17
Overweight
↔ Maintain
Mizuho
2026-07-17
Neutral
↔ Maintain
Wells Fargo
2026-07-17
Overweight
↔ Maintain
TD Cowen
2026-07-17
Buy
↔ Maintain
Evercore ISI Group
2026-07-17
In-Line
↔ Maintain
RBC Capital
2026-07-17
Outperform
↔ Maintain
Stifel
2026-07-17
Buy
↔ Maintain
Citigroup
2026-07-17
Buy
↔ Maintain
Bernstein
2026-07-17
Outperform
↔ Maintain
Leerink Partners
2026-07-17
Outperform
↔ Maintain
Baird
2026-07-17
Outperform
↔ Maintain
BTIG
2026-07-17
Buy
↔ Maintain
Truist Securities
2026-07-16
Buy
↔ Maintain
BMO Capital
2026-07-09
Outperform
● Initiate
B of A Securities
2026-05-18
Buy
↔ Maintain
Barclays
2026-04-23
Overweight
↔ Maintain
Goldman Sachs
2026-04-09
Buy
↔ Maintain
UBS
2026-03-17
Neutral
↔ Maintain
Freedom Capital Markets
2026-01-27
Buy
(from Hold)
▲ Upgrade
Freedom Broker
2026-01-26
Buy
(from Hold)
▲ Upgrade
Profitability
Gross Margin
66.68%TTM
Op. Margin
33.60%TTM
ROE
17.42%TTM
Rev. Growth
18.50%YoY
Free Cash Flow
2.62BTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
N/AMRQ
Current Ratio
4.96MRQ
Cash
5.22BMRQ
Total Debt
0.00MRQ
Net Debt
—MRQ
How ISRG Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 126.51B |
| Enterprise Value | 119.66B |
| Trailing P/E | 41.49 |
| Forward P/E | 29.25 |
| PEG Ratio (5yr) | 1.78 |
| Price/Sales (ttm) | 11.46 |
| Price/Book (mrq) | 6.88 |
| EV/Revenue | 10.84 |
| EV/EBITDA | 28.62 |
Share Statistics
| Avg Vol (3m) | 2.98M |
| Shares Outstanding | 358.28M |
| Float | 351.21M |
| % Held by Insiders | 0.51% |
| % Held by Institutions | 89.40% |
| Short Ratio | 2.42 |
| Short % of Float | 1.90% |
Profitability
| Gross Margin | 66.68% |
| Operating Margin (ttm) | 33.60% |
| Profit Margin | 28.45% |
| Return on Assets (ttm) | 10.51% |
| Return on Equity (ttm) | 17.42% |
Income Statement
| Revenue (ttm) | 11.03B |
| Revenue Growth (yoy) | 18.50% |
| Gross Profit (ttm) | 7.36B |
| EBITDA | 4.18B |
| Net Income (ttm) | 3.14B |
| Diluted EPS (ttm) | 8.51 |
| EPS Growth (yoy) | 26.50% |
Balance Sheet
| Total Cash (mrq) | 5.22B |
| Total Debt (mrq) | 0.00 |
| Debt / Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.96 |
| Book Value / Share | 51.34 |
| Operating CF (ttm) | 3.71B |
| Free Cash Flow (ttm) | 2.62B |
Trading & Dividends
| Beta (5Y) | 1.46 |
| 50-Day MA | 404.26 |
| 200-Day MA | 483.12 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
Ownership Breakdown
Institutional 89.40%
Insider 0.51%
Public 10.1%
Short Interest
1.90% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in ISRG in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-10 | ROSA DAVID J | Chief Executive Officer | 1,910 | — | |
| 2026-06-12 | BROSIUS MARK PRESTON | Officer | Sale at price 412.16 - 414.13 per share. | 48 | $19,833 |
| 2026-06-10 | ROSA DAVID J | Chief Executive Officer | 1,358 | — | |
| 2026-06-10 | BROSIUS MARK PRESTON | Officer | Sale at price 420.12 - 424.14 per share. | 69 | $29,104 |
| 2026-06-10 | LOEB GARY | Officer | Sale at price 424.14 per share. | 400 | $169,656 |
| 2026-06-01 | JEDDI IMAN | Officer | Conversion of Exercise of derivative security at price 77.00 per share. | 5,625 | $433,119 |
| 2026-06-01 | JEDDI IMAN | Officer | Sale at price 420.55 per share. | 5,625 | $2,365,594 |
| 2026-05-22 | BROSIUS MARK PRESTON | Officer | Sale at price 439.80 - 446.04 per share. | 36 | $15,945 |
| 2026-05-20 | BROSIUS MARK PRESTON | Officer | Sale at price 422.47 - 440.70 per share. | 54 | $23,464 |
| 2026-05-11 | LOEB GARY | Officer | Sale at price 446.95 per share. | 400 | $178,780 |
| 2026-04-30 | REED MONICA P | Director | 531 | — | |
| 2026-04-30 | KOLLI SREELAKSHMI | Director | 531 | — | |
| 2026-04-30 | LADD AMY L | Director | 531 | — | |
| 2026-04-30 | LEONARD KEITH R JR | Director | 531 | — | |
| 2026-04-30 | CHEW LEWIS | Director | 531 | — | |
| 2026-04-30 | JOHNSON AMAL M | Director | 531 | — | |
| 2026-04-30 | BARRATT CRAIG H | Director | 750 | — | |
| 2026-04-30 | BEERY JOSEPH C | Director | 531 | — | |
| 2026-04-30 | NACHTSHEIM JAMI DOVER K | Director | 531 | — | |
| 2026-04-29 | LADD AMY L | Director | Sale at price 463.50 - 473.46 per share. | 619 | $291,886 |
| 2026-03-10 | CURET MCADAMS MYRIAM J | Officer | Conversion of Exercise of derivative security at price 229.39 per share. | 105 | $24,086 |
| 2026-03-10 | CURET MCADAMS MYRIAM J | Officer | Sale at price 493.95 per share. | 105 | $51,865 |
| 2026-03-09 | BROSIUS MARK PRESTON | Officer | Sale at price 485.01 - 490.19 per share. | 1,293 | $630,475 |
| 2026-03-05 | BROSIUS MARK PRESTON | Officer | Sale at price 488.10 - 498.68 per share. | 3,658 | $1,815,062 |
| 2026-03-03 | CURET MCADAMS MYRIAM J | Officer | Sale at price 487.18 - 492.59 per share. | 4,853 | $2,364,961 |
ROSA DAVID J
Chief Executive Officer
2026-07-10
1,910 sh
—
BROSIUS MARK PRESTON
Officer
Sale at price 412.16 - 414.13 per share.
2026-06-12
48 sh
$19,833
ROSA DAVID J
Chief Executive Officer
2026-06-10
1,358 sh
—
BROSIUS MARK PRESTON
Officer
Sale at price 420.12 - 424.14 per share.
2026-06-10
69 sh
$29,104
LOEB GARY
Officer
Sale at price 424.14 per share.
2026-06-10
400 sh
$169,656
JEDDI IMAN
Officer
Conversion of Exercise of derivative security at price 77.00 per share.
2026-06-01
5,625 sh
$433,119
JEDDI IMAN
Officer
Sale at price 420.55 per share.
2026-06-01
5,625 sh
$2,365,594
BROSIUS MARK PRESTON
Officer
Sale at price 439.80 - 446.04 per share.
2026-05-22
36 sh
$15,945
BROSIUS MARK PRESTON
Officer
Sale at price 422.47 - 440.70 per share.
2026-05-20
54 sh
$23,464
LOEB GARY
Officer
Sale at price 446.95 per share.
2026-05-11
400 sh
$178,780
REED MONICA P
Director
2026-04-30
531 sh
—
KOLLI SREELAKSHMI
Director
2026-04-30
531 sh
—
LADD AMY L
Director
2026-04-30
531 sh
—
LEONARD KEITH R JR
Director
2026-04-30
531 sh
—
CHEW LEWIS
Director
2026-04-30
531 sh
—
JOHNSON AMAL M
Director
2026-04-30
531 sh
—
BARRATT CRAIG H
Director
2026-04-30
750 sh
—
BEERY JOSEPH C
Director
2026-04-30
531 sh
—
NACHTSHEIM JAMI DOVER K
Director
2026-04-30
531 sh
—
LADD AMY L
Director
Sale at price 463.50 - 473.46 per share.
2026-04-29
619 sh
$291,886
CURET MCADAMS MYRIAM J
Officer
Conversion of Exercise of derivative security at price 229.39 per share.
2026-03-10
105 sh
$24,086
CURET MCADAMS MYRIAM J
Officer
Sale at price 493.95 per share.
2026-03-10
105 sh
$51,865
BROSIUS MARK PRESTON
Officer
Sale at price 485.01 - 490.19 per share.
2026-03-09
1,293 sh
$630,475
BROSIUS MARK PRESTON
Officer
Sale at price 488.10 - 498.68 per share.
2026-03-05
3,658 sh
$1,815,062
CURET MCADAMS MYRIAM J
Officer
Sale at price 487.18 - 492.59 per share.
2026-03-03
4,853 sh
$2,364,961